Robert Chaplin
Private equity firms paid $8.3bn in fees to investment banks in the first half, according to Dealogic, the highest amount since 2007.
French asset manager IdInvest Partners has bought a 40% stake in Kurma Life Sciences Partners, a venture firm founded by two of its former executives, in a deal that provides an exit for previous backer Natixis Private Equity.
UK-based Albion booked a return of more three times its investment following the £40m sale to Perform Group.